Purchase Order 15B10926P00000044
- Not listed
- McKesson Corporation, a major healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, has been awarded a firm fixed-price purchase order by the Federal Medical Center Lexington for multiple invoices of medication shipments. The contract, valued at a ceiling of $16.28M, covers pharmaceutical supplies required for federal correctional healthcare operations during January 2026, with an ultimate completion date of January 31, 2026. This award represents no...
- McKesson Corporation, the prime contractor headquartered in Irving, Texas, has been awarded a $17.4M purchase order by the Federal Medical Center Lexington, a civilian facility under the Bureau of Prisons. This firm fixed-price contract, awarded on March 1, 2026, covers multiple invoices for medication shipments required through March 31, 2026. The work will be performed at McKesson's Irving, Texas location, and no small business set-aside designation was utilized in this procurement. This award...
- McKesson Corporation, a major pharmaceutical distribution company headquartered in Irving, Texas, has been awarded a delivery order valued at $696,288.94 by the Federal Medical Center Lexington, a civilian facility within the Bureau of Prisons. This firm fixed-price delivery order, designated B1 for non-controlled and controlled substances, runs through January 31, 2026, with an award date of January 1, 2026. The contract contains no small business set-aside designation, reflecting McKesson's...
- The Department of Justice Bureau of Prisons Federal Medical Center in Lexington awarded McKesson Corporation a $17,956.85 purchase order to supply medications. Under the terms of the non-contract award, McKesson will ship medications to the correctional facility in Irving, Texas between September 1st and October 23rd, 2023. As the largest pharmaceutical distributor in the U.S., McKesson will fulfill this requirement from their distribution center in Irving. No subcontractors or set-aside...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation, doing business as Mckesson, a $438,683.91 firm fixed price delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases through multiple invoice shipments received in October 2022. Mckesson will fulfill this contract from its location in Irving, Texas, starting on December 1, 2022 through January 18, 2023. As one of the largest...
- Mckesson Corporation has been awarded a firm fixed price purchase order by the Department of Justice Bureau of Prisons Federal Medical Center Lexington. The purchase order, valued at $23,283.64, is to provide unspecified products or services from January 1, 2024 through February 12, 2024 under a non-set aside contract. Mckesson will perform as the prime contractor, with work taking place in Irving, Texas. No further details were provided on the specific requirements of this purchase order.
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation a $463,576.85 delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases through multiple invoices for medication shipments received from January through February 2023. Mckesson Corporation will perform as the prime contractor under a firm fixed price contract to supply pharmaceutical products to the correctional healthcare facility...
- McKesson Corporation was awarded a delivery order valued at $543,762.08 by the Federal Medical Center Lexington for routine wholesale medication purchases covering non-controlled and controlled substances. The award, effective November 1, 2025, with an ultimate completion date of November 30, 2025, represents multiple invoices for medication shipments received during the first month of fiscal year 2025. The contract was awarded on a firm fixed-price basis with no set-aside designation and...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded McKesson Corporation, doing business as McKesson Drug Company, a $167,305.48 firm fixed price delivery order contract to provide routine wholesale non-controlled and controlled substance medication purchases from October through December 2023. McKesson, a wholly owned subsidiary of McKesson Corporation, will fulfill multiple invoices for medication shipments from its location in Irving, Texas to the Bureau of...
- The Department of Justice Bureau of Prisons Federal Medical Center Lexington awarded Mckesson Corporation, doing business as Mckesson, a $287,645.47 firm fixed price delivery order contract to provide non-controlled and controlled substances for routine wholesale medication purchases through multiple invoices for medication shipments received from November 1, 2022 through December 9, 2022. Mckesson will supply pharmaceutical products to the Federal Medical Center Lexington facility located in...
McKesson Corporation, a major healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, has been awarded a purchase order by the Federal Medical Center Lexington for multiple invoices related to medication shipments. The contract, awarded on February 1, 2026, carries a ceiling value of $18,027.09 under a firm fixed price arrangement with an ultimate completion date of March 22, 2026. The place of performance is Irving, Texas, where McKesson maintains significant pharmaceutical distribution infrastructure. No small business set-aside designation was utilized for this award, consistent with McKesson's established competitive standing as a large business in federal procurement. This purchase order supports the Federal Medical Center Lexington's pharmaceutical supply requirements for fiscal year 2026 and reflects McKesson's extensive engagement with the Bureau of Prisons system within the Department of Justice. McKesson maintains a substantial federal contract portfolio providing controlled and non-controlled medications, specialty pharmaceuticals, and medical supplies to federal correctional facilities nationwide. The award is consistent with the company's critical role as a pharmaceutical supplier to federal healthcare operations and demonstrates the ongoing reliance of the Federal Bureau of Prisons on McKesson's distribution capabilities for institutional medical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 3/3/26 |